The epidemiology and control of open angle glaucoma: A population-based perspective

Annual Review of Public Health

Volumn 17, Issue , 1996, Pages 121-136

  Tielsch, James M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cost; prevalence; risk factors; screening

Indexed keywords

CATARACT; CONFERENCE PAPER; EYE DEVELOPMENT; EYE INJURY; HUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RISK FACTOR; UVEITIS; VISUAL IMPAIRMENT;

EID: 0029928269     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pu.17.050196.001005     Document Type: Conference Paper

References (85)

1. Airaksinen PJ, Drance SM, Douglas GR, Mawson DK, Nieminen H. 1984. Diffuse and localized nerve fiber layer loss in glaucoma. Am. J. Ophthalmol. 98:566-71
2. Anderson DR. 1989. Glaucoma: the damage caused by pressure. XLVI Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 108:485-95
3. Armaly MF. 1967. Genetic determination of cup/disc ratio of the optic nerve. Arch. Ophthalmol. 78:35-43
4. Armaly MF. 1967. The genetic determinants of ocular pressure in the normal eye. Arch. Ophthalmol. 78:187-92
5. Armaly MF. 1980. Lessons to be learned from the Collaborative Glaucoma Study. Surv. Ophthalmol. 25:139-44
6. Armaly MF, Krueger DE, Maunder L, Becker B, Hetherington J Jr, et al. 1980. Biostatistical analysis of the Collaborative Glaucoma Study. I. Summary report of the risk factors for glaucomatous visual field defects. Arch. Ophthalmol. 98:2163-71
7. Armaly MF, Monstavicius BF, Sayegh RE. 1968. Ocular pressure and aqueous outflow facility in siblings. Arch. Ophthalmol. 80:354-60
8. Becker B, Kolker AE, Roth FD. 1960. Glaucoma family study. Am. J. Ophthalmol. 50:557-67
9. Bengtsson B. 1981. Aspects of the epidemiology of chronic glaucoma. Acta Ophthalmol. 146(Suppl.):4-26
10. Bengtsson B. 1981. The prevalence of glaucoma. Br. J. Ophthalmol. 65: 46-49
11. Bernth-Peterson P. 1982. Outcomes of cataract surgery. II. Visual functioning in aphakic patients. Acta Ophthalmol. 60:243-51
12. Brav SS, Kirber HP. 1951. Mass screening for glaucoma. JAMA 147:1127-8
13. Caprioli J, Miller JM. 1988. Videographic measurements of optic nerve topography in glaucoma. Invest. Ophthalmol. Vis. Sci. 29:1294-98
14. Caprioli J, Spaeth GL. 1984. Comparison of visual field defects in low-tension and high-tension glaucoma. Am. J. Ophthalmol. 97:730-37
15. Cartwright MJ, Anderson DR. 1988. Correlation of asymmetric damage with asymmetric intraocular pressure in normal tension glaucoma. Arch. Ophthalmol. 106:898-900
16. Chauhan BC, Drance SM, Douglas GR, Johnson CA. 1989. Visual field damage in normal-tension and high-tension glaucoma. Am. J. Ophthalmol. 108: 636-42
17. Coffey M, Reidy A, Wormold R, Xian WX, Wright L, Courtney P. 1993. Prevalence of glaucoma in the west of Ireland. Rr. J. Ophthalmol. 77:17-21
18. Coulehan JL, Helzlsouer KJ, Rodgers KD, Brown SI. 1980. Racial differences in intraocular tension and glaucoma surgery. Am. J. Epidemiol. 111:759-68
19. Crichton A, Drance SM, Douglas GR, Schulzer M. 1989. Unequal intraocular pressure and its relation to asymmetric visual field defects in low tension glaucoma. Ophthalmology 96:1312-14
20. Dielemans I, Vingerling JR, Wolfs RCW, Hofman A, Grabbee DE, de Jong PTVM. 1994. The prevalence of primary open-angle glaucoma in a population based study in the Netherlands. Ophthalmology 101:1851-55
21. Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. 1988. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am. J. Ophthalmol. 105: 35-39
22. Eddy DM, Sanders LE, Eddy JF. 1983. The value of screening for glaucoma with tonometry. Surv. Ophthalmol. 28: 194-205
23. Frydman JE, Clower JW, Fulghum JE, Hester MW. 1966. Glaucoma detection in Florida. JAMA 198:1237-40
24. Grant WM, Burke JF. 1982. Why do some people go blind from glaucoma? Ophthalmology 89:991-98
25. Hollows FC, Graham PA. 1966. Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br. J. Ophthalmol. 50:570-86
26. Hoyt WF, Frisen L, Newman NM. 1973. Fundoscopy of nerve fiber layer defects in glaucoma. Invest. Ophthalmol. Vis. Sci. 12:814-29
27. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, et al. 1977. The Framingham Eye Study II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am. J. Epidemiol. 106:33-41
28. Kahn HA, Milton RC. 1980. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham Eye Study. Arch. Ophthalmol. 98:2172-79
29. Kahn HA, Milton RC. 1980. Revised Framingham Eye Study prevalence of glaucoma and diabetic retinopathy. Am. J. Epidemiol. 111:769-76
30. Kahn HA, Moorhead HB. 1973. Statistics on Blindness in the Model Reporting Area 1969-1970. US DHEW Publ. No. (NIH) 73-427
31. Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolker AE, et al. 1989. Topical Timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch. Ophthalmol. 107: 1590-98
32. Kass MA, Palmberg P, Becker B, Miller JP. 1978. Histocompatibility antigens and primary open-angle glaucoma. A reassessment. Arch. Ophthalmol. 96: 2207-8
33. Katz J, Sommer A. 1988. Risk factors for primary open angle glaucoma. Am. J. Prev. Med. 4:110-14
34. Kellerman L, Posner A. 1955. The value of heredity in the detection and study of glaucoma. Am. J. Ophthalmol. 40: 681-85
35. Klein BE, Klein R. 1981. Intraocular pressure and cardiovascular risk factors. Arch. Ophthalmol. 99:837-39
36. Klein BEK, Klein R, Jensen SC. 1994. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology 101:1173-77
37. Klein BEK, Klein R, Mever SM, Goetz LA. 1993.. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest. Ophthalmol. Vis. Sci. 34:3024-27
38. Klein BEK, Klein R, Sponsel WE, Franke T, Cantor LB, et al. 1992. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 99:1499-504
39. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, et al. 1980. The Framingham Eye Study Monograph. Surv. Ophthalmol. 24(Suppl.): 335-610
40. Leske MC, Connell AMS, Schachat RP, Hyman L, and the Barbados Eye Study Group. 1994. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch. Ophthalmol 112:821-29
41. Leske MC, Ederer F, Podgor M. 1981. Estimating incidence from age-specific prevalence in glaucoma. Am. J. Epidemiol. 113:606-13
42. Leske MC, Podgor MJ. 1983. Intraocular pressure, cardiovascular risk variables and visual field defects. Am. J. Epidemiol. 118:280-87
43. Lewis RA, Heyreh SS, Phelps CD. 1983. Optic disc and visual field correlations in primary open angle and low tension glaucoma. Am. J. Ophthalmol. 96: 148-52
44. Lichter PR. 1994. Genetic clues to glaucoma's secrets. The L. Edward Jackson Memorial Lecture. Part 2. Am. J. Ophthalmol. 117:706-27
45. Lindblom B, Thorborn W. 1982. Prevalence of visual field defects due to capsular and simple glaucoma in Halsingland, Sweden. Acta Ophthalmol. 60: 353-61
46. Mangione CM, Phillips RS, Seddon JM, Lawrence MG, Cook EF, et al. 1992. Development of the Activities of Daily Vision Scale: a measure of visual functional status. Med. Care 30:1111-26
47. Martin MJ, Sommer A, Gold EB, Diamond EL. 1985. Race and primary open angle glaucoma. Am. J. Ophthalmol. 99:383-87
48. Mason RP, Kosoko O, Wilson MR, Martone JF, Cowan CL Jr, et al. 1989. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I: prevalence findings. Ophthalmology 96:1363-68
49. McLeod SD, West SK, Quigley HA, Fozard JL. 1990. A longitudinal study of the relationship between intraocular and blood pressures. Invest. Ophthalmol. Vis. Sci. 31:2361-66
50. Morgan RW, Drance SM. 1975. Chronic open-angle glaucoma and ocular hypertension: an epidemiological study. Br. J. Ophthalmol. 59:211-15
51. Patel KH, Javitt JC, Tielsch JM, Street DA, Katz J, et al. 1995. Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am. J. Ophthalmol. In press
52. Perkins ES. 1973. The Bedford glaucoma survey. I. Long-term follow-up of borderline cases. Br. J. Ophthalmol. 57: 179-85
53. Perkins ES, Phelps CD. 1982. Open angle glaucoma, ocular hypertension, low tension glaucoma, and refraction. Arch. Ophthalmol. 100:1464-67
54. Phelps CD, Corbett JJ. 1985. Migraine and low-tension glaucoma. A case-control study. Invest. Ophthalmol. Vis. Sci. 26:1105-8
55. Ponte F, Giuffre G, Giammanco R, Dardononi G. 1994. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc. Ophthalmol. 85:203-10
56. Quigley HA, Enger C, Katz J, Sommer A, Scott R, Gilbert D. 1994. Risk factors for the developoment of glaucomatous visual field loss in ocular hypertension. Arch. Ophthalmol. 112:644-49
57. Reynolds DC. 1977. Relative risk factors in chronic open angle glaucoma: an epidemiological study. Am. J. Optom. Physiol. Optics 54:116-20
58. Shin DH, Becker B. 1977. HLA-A11 and HLA-Bw35 and resistance to glaucoma in white patients with ocular hypertension. Arch. Ophthalmol. 95: 423-24
59. Shin DH, Becker B, Waltman SR, Palmberg PF, Bell E Jr. 1977. The prevalence of HLA-B12 and HLA-B7 antigens in primary open-angle glaucoma. Arch. Ophthalmol. 95:224-25
60. Sommer A. 1989. Intraocular pressure and glaucoma. Am. J. Ophthalmol. 107: 186-88
61. Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, et al. 1991. Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol. 109:77-83
62. Sommer A, Quigley HA, Robin AL, Miller NR, Katz J, Arkell S. 1984. Evaluation of nerve fiber layer assessment. Arch. Ophthalmol. 102:1766-71
63. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, et al. 1991. Racial differences in the cause-specific prevalence of blindness in east Baltimore. M Engl. J. Med. 325:1412-17
64. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, et al. 1991. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch. Ophthalmol. 109:1090-95
65. Sponsel WE, Ritch R, Stamper R, Higginbotham EJ, Anderson D, et al. 1995. Prevent Blindness America visual field screening study. Am. J. Ophthalmol. In press
66. Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, et al. 1994. The VF-14. An index of functional impairment in patients with cataract. Arch. Ophthalmol. 112:630-38
67. Steinmann W, Stone R, Nichols C, Werner E, Schweitzer J, et al. 1983. A case-control study of the association of sickle cell trait and chronic open-angle glaucoma. Am. J. Epidemiol. 118:288-93
68. Thylefors F, Negrel A-D. 1994. The global impact of glaucoma. Bull WHO 72:323-26
69. Tielsch JM. 1993. Therapy for glaucoma: costs and consequences. In Glaucoma: Diagnosis and Therapy. Trans. New Orleans Acad. Ophthalmol., ed. SF Ball, RM Franklin, pp. 61-68. Amsterdam: Kugler
70. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. 1995. Diabetes and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 102: 48-53
71. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. 1995. Hypertension, perfusion pressure and primary open angle glaucoma: a population-based assessment. Arch. Ophthalmol. 113:216-21
72. Tielsch JM, Katz J. Quigley HA, Miller NR, Sommer A. 1988. Intraobserver and interobserver agreement in measurement of optic disc characteristics. Ophthalmology 95:350-56
73. Tielsch JM, Katz J, Singh K, Quigley HA, Gottsch JD, et al. 1991. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am. J. Epidemiol. 134:1102-10
74. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. 1994. Family history and risk of primary open angle glaucoma: the Baltimore Eye Survey. Arch. Ophthalmol. 112:69-73
75. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. 1991. Racial variations in the prevalence of primary open angle glaucoma: the Baltimore Eye Survey. JAMA. 266:369-74
76. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. 1990. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch. Ophthalmol. 108:286-90
77. Uhm KB, Shin DH. 1992. Positive family history of glaucoma is a risk factor for increased IOP rather than glaucomatous optic nerve damage (POAG vs OH vs Normal Control). Korean J. Ophthalmol. 6:100-4
78. Van Buskirk EM. 1994. Glaucomatous optic neuropathy. J. Glaucoma 3:S2-S3
79. Varma R, Spaeth GL. 1988. The PAR IS 2000: a new system for retinal digital image analysis. Ophthal. Surg. 19:183-92
80. Viggosson G, Bjornsson G, Ingvason JG. 1986. The prevalence of open-angle glaucoma in Iceland. Acta Ophthalmol. 64:138-41
81. Wallace J, Lovell HG. 1969. Glaucoma and intraocular pressure in Jamaica. Am. J. Ophthalmol. 67:93-100
82. Weinreb RN, Dreher AW, Bille JF. 1989. Quantitative assessment of the optic nerve head with the laser tomographic scanner. Int. Ophthalmol. 13: 25-29
83. Wilensky JT, Gandhi N, Pan T. 1978. Racial influences in open angle glaucoma. Am. J. Ophthalmol. 10:1398-402
84. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. 1987. A case-control study of risk factors in open angle glaucoma. Arch. Ophthalmol. 105: 1066-71
85. Wilson R, Richardson TM, Hertzmark E, Grant WM. 1985. Race as a risk factor for progressive glaucomatous damage. Ann. Ophthalmol. 17:653-59